US Distributor Demands Better Biosimilars Support

 
• By Aidan Fry

Removing legal hurdles and putting biosimilars on preferred formulary tiers will increase access and cut the cost of biologic therapies in the US, argues the chief of major healthcare distributor AmerisourceBergen.

Amerisource
AmerisourceBergen boss Steve Collis argues that US policymakers must give better support to biosimilars • Source: Shutterstock

More from Biosimilars

More from Products